Cancer BiologybioRxiv
High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma
DOI 10.1093/neuonc/noae104
Author
Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet , Stockholm , Sweden
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
1 paper
Recent·Most cited